Nagendran Sukumar sold TSHA
December 1, 2025 · Form 4 insider transaction
Nagendran Sukumar sold 260,047 shares of Taysha Gene Therapies, Inc. at $4.51 per share, a transaction worth $1.17M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
260,047
Price
$4.51
Total value
$1.17M
InsiderNagendran Sukumar
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 1, 2025
Filing dateDecember 1, 2025
Shares owned after1,006,439
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.42 to $4.63 inclusive.